Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

New drugs for heart disease may be developed from molecules secreted by stem cells.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Finasteride may help reduce inappropriate sexual behaviors in dementia patients with prostate issues.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Bald men may have a higher risk of heart disease, but baldness doesn't necessarily mean more severe heart disease.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

Finasteride reduces prostate size and PSA levels in young patients.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Hair loss linked to prostate enlargement; stress and family history important factors.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Pumpkin seed oil may improve prostate health, bladder control, and hair growth in men.

Kawasaki's disease can occur in adults and should be considered with specific symptoms and high ferritin levels.